title: [Epidemio-clinical aspects of adult acute bacterial pneumonia at Yalgado Ouédraogo University Health Center].
abstract: BACKGROUND
  Bacterial Pneumopathies are low respiratory infections due to parenchyma pulmonary attack, which etiologic agent is a bacteria different from tubercular bacillus. Factually, the treatment is based on a probalistic antibiotherapy. This requires awareness of the epidemiology of the germs which are responsible in a given region, at a given period.
  
  
  METHODS
  In order to better grasp mainly the bacteriological and therapeutic aspects of adult bacterial Pneumopathies in Burkina Faso, we have come up with a two year journal/documentary.
  
  
  RESULTS
  The reported most frequent germs are respectively: Streptococcus pneumoniae (32,6%), Klebsiella pneumoniae (21%) et Staphylococcus aureus (13,9%). Negative Gram bacteries represented 53.5% of isolated germ and Acinetobacter was found only with HIV positive patients. The streptococcus was sensitive to association amoxicilline + clavulanic in 91.7% of the cases, to ceftriaxone in 83.3% of cases, to ampicilline and to amoxicilline in 66.7% of cases The clinical evolution of our patients was favorable in 74.5% of the cases with 21.8% deaths. The evolution was more significant within alcoholic patients (p = 0.001) as well as tobacco addicted patients (p = 0.02).
  
  
  CONCLUSIONS
  The high morbi-morbidity due to acute pneumopathy could be improved through a better awareness and regular updating of local bacterial ecology.
authors: Service de medecine interne CHU Sanou Souro, Mali.
authors: S M
authors: SM
authors: Ouédraogo
authors: Y
authors: Y
authors: Toloba
authors: G
authors: G
authors: Badoum
authors: G
authors: G
authors: Ouédraogo
authors: K
authors: K
authors: Boncoungou
authors: M
authors: M
authors: Bambara
authors: E W M
authors: EW
authors: Ouédraogo
authors: A
authors: A
authors: Zigani
authors: L
authors: L
authors: Sangaré
authors: M
authors: M
authors: Ouédraogo
mesh_terms: D000208:Acute Disease; D000328:Adult; D000437:Alcoholism / Q000453:epidemiology; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002050:Burkina Faso / Q000453:epidemiology; D015897:Comorbidity; D003428:Cross Infection / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D005260:Female; D016905:Gram-Negative Bacterial Infections / Q000453:epidemiology; D016908:Gram-Positive Bacterial Infections / Q000453:epidemiology; D015658:HIV Infections / Q000453:epidemiology; D006748:Hospital Departments / Q000706:statistics & numerical data; D017052:Hospital Mortality; D006785:Hospitals, University / Q000706:statistics & numerical data*; D006801:Humans; D008297:Male; D008875:Middle Aged; D018410:Pneumonia, Bacterial / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D015272:Pulmonary Medicine / Q000706:statistics & numerical data; D012189:Retrospective Studies; D012907:Smoking / Q000453:epidemiology; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents